Congratulations and welcome to Reza Vagefi, MD, who joined the Tufts Medicine family as Chair of Ophthalmology at Tufts Medical Center and Professor and Chair of Ophthalmology for Tufts University School of Medicine in April of 2023.
Dr. Katie Huber and her husband Chris Tarmey recently established the Joey and Anne’s Helping Hands Fund, to provide direct financial support to cancer patients in need.
A comprehensive review study has found that Medicaid and commercial insurance coverage policies for Biogen Alzheimer’s disease drug, Aduhelm, showed large inconsistencies based on plan and geography.
Taysir Mahmoud holds the newly created position of Supervisor of Clinical and Translational Research in MIRI, OB/Gyn and Pediatrics to accomplish that task.
Tufts MC's Predictive Analytics and Comparative Effectiveness (PACE) Center the Recipient of National Institute of Neurological Disorders and Stroke (NINDS) Grant.
Researchers from the Division of Endocrinology at Tufts Medical Center found that vitamin D was effective in lowering the risk for developing diabetes in adults with prediabetes.
In order to further strengthen the connection between the MIRI and investigators involved in complementary work across Tufts Medicine and Tufts University, MIRI created the role of "Associate PI."
Once barely able to walk and given less than six months to live, Linda DaCosta is alive and thriving years later, thanks to her care at Tufts Medical Center.
MIRI PI Patrick Catalano, MD, has been awarded an R21 from the NIH/NICHD as Multi-Site PI for a two-year study entitled, “Impact of a Postpartum Lifestyle Intervention on Lactation Outcomes, Breastmilk Composition and Infant Growth.”
Michael House, MD, has been recognized as an expert in the uterine cervix, has received an SMFM/ABOG Bridge Grant entitled “Novel tools for studying cervical function and dysfunction during pregnancy.”
For years, glioblastoma, an aggressive form of brain cancer, has frustrated scientists and researchers. But while there is no known cure for this deadly disease, new, cutting-edge research may provide a life-prolonging option for glioblastoma patients and their families.